AEMD
NASDAQ
US
Aethlon Medical, Inc. - Common Stock
$2.12
▼ $-0.03
(-1.40%)
Vol 19K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$2.1M
ROE
-241.8%
Margin
-433.3%
D/E
0.00
Beta
1.52
52W
$2–$84
Wall Street Consensus
7 analysts · Apr 20260
Strong Buy
0
Buy
4
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-2.47 | $-2.45 | +$0.02 |
| Sep 2025 | $-3.74 | $-3.74 | $0.00 |
| Jun 2025 | $-8.77 | $-8.50 | +$0.27 |
| Mar 2025 | $-10.30 | $-79.70 | $-69.40 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Net Income | — | -$1.8M | -$6.3M | -$1.8M | -$1.5M | -$2.0M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -266.2% | -221.2% | -266.2% | -266.2% | -266.2% | -241.8% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -433.3% | -433.3% | -433.3% | -433.3% | -433.3% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 2.49 | 3.13 | 2.49 | 2.49 | 2.49 | 4.45 |
Key Ratios
ROA (TTM)
-169.9%
P/S (TTM)
3.70
P/B
1.4
EPS (TTM)
$-56.69
CF/Share
$-4.75
52W High
$84.40
52W Low
$2.46
$2.46
52-Week Range
$84.40
Financial Health
Free Cash Flow
-$1.9M
Net Debt
-$6.5M
Cash
$7.0M
Total Debt
$418K
As of Dec 31, 2025
How does AEMD compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
AEMD valuation vs Health Care peers
P/E ratio
—
▼
0%
below
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
3.7
▲
43%
above
peers
(2.6)
vs Peers
vs Industry
Pricier
P/B ratio
1.4
▼
48%
below
peers
(2.8)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
AEMD profitability vs Health Care peers
ROE
-241.8%
▼
528%
below
peers
(-38.5%)
vs Peers
vs Industry
Weak
Net margin
-433.3%
▼
1655%
below
peers
(-24.7%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(52.9%)
vs Peers
vs Industry
Top tier
ROA
-169.9%
▼
700%
below
peers
(-21.2%)
vs Peers
vs Industry
Weak
AEMD financial health vs Health Care peers
D/E ratio
0.0
▼
100%
below
peers
(19.3)
vs Peers
vs Industry
Low debt
Current ratio
4.5
▲
106%
above
peers
(2.2)
vs Peers
vs Industry
Strong liquidity
Beta
1.5
▲
44%
above
peers
(1.1)
vs Peers
vs Industry
More volatile
AEMD fundamentals radar
AEMD
Peer median
Industry
AEMD profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
AEMD vs peers: key metrics
Top Holders
Top 5: 1.05%Ikarian Capital, LLC
0.92%
$31K
Morgan Stanley
0.13%
$4K
Citigroup Inc.
$70
Group One Trading, LLC
$30
Blackrock Inc.
$21
As of Dec 31, 2025
Latest News
No related news yet